An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease

Journal of Vascular Surgery

Volumn 56, Issue 3, 2012, Pages 686-695

  Owens, Christopher D ^a   Kim, Ji Min ^a   Hevelone, Nathanael D ^b,c   Gasper, Warren J ^a   Belkin, Michael ^c   Creager, Mark A ^c   Conte, Michael S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Center for Surgery and Public Health   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; LIPID; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BYPASS SURGERY; CARDIOVASCULAR RISK; CHEMICAL PARAMETERS; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; LOWER EXTREMITY BYPASS SURGERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREDICTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SURVIVOR; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; DECISION SUPPORT TECHNIQUES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION MEDIATORS; LIFE TABLES; LIPIDS; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULAR SURGICAL PROCEDURES;

EID: 84865230663     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.02.034     Document Type: Article

References (34)

1. J. Stamler, R. Stamler, J.D. Neaton, D. Wentworth, M.L. Daviglus, D. Garside Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women JAMA 282 1999 2012 2018
2. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, I. Gillespie Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: a survival prediction model to facilitate clinical decision making J Vasc Surg 51 5 Suppl 2010 52S 68S
3. P.P. Goodney, B.W. Nolan, A. Schanzer, J. Eldrup-Jorgensen, A.C. Stanley, D.H. Stone Factors associated with death 1 year after lower extremity bypass in northern New England J Vasc Surg 51 2010 71 78
4. A. Schanzer, J. Mega, J. Meadows, R.H. Samson, D.F. Bandyk, M.S. Conte Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data J Vasc Surg 48 2008 1464 1471
5. R.G. DePalma, V.W. Hayes, H.T. Cafferata, H.A. Mohammadpour, B.K. Chow, L.R. Zacharski Cytokine signatures in atherosclerotic claudicants J Surg Res 111 2003 215 221 (Pubitemid 36808912)
6. M.M. McDermott, J.M. Guralnik, A. Corsi, M. Albay, C. Macchi, S. Bandinelli Patterns of inflammation associated with peripheral arterial disease: the InCHIANTI study Am Heart J 150 2005 276 281 (Pubitemid 41116253)
7. H. Vidula, L. Tian, K. Liu, M.H. Criqui, L. Ferrucci, W.H. Pearce Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study Ann Intern Med 148 2008 85 93 (Pubitemid 351651551)
8. N.S. Jenny, N.D. Yanez, B.M. Psaty, L.H. Kuller, C.H. Hirsch, R.P. Tracy Inflammation biomarkers and near-term death in older men Am J Epidemiol 165 2007 684 695 (Pubitemid 46348379)
9. T. Vainas, F.R. Stassen, R. de Graaf, E.L. Twiss, S.B. Herngreen, R.J. Welten C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events J Vasc Surg 42 2005 243 251 (Pubitemid 41139229)
10. C.D. Owens, P.M. Ridker, M. Belkin, A.D. Hamdan, F. Pomposelli, F. Logerfo Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery J Vasc Surg 45 2007 2 9 discussion: 9 (Pubitemid 46038651)
11. J. Barani, J.A. Nilsson, I. Mattiasson, B. Lindblad, A. Gottster Inflammatory mediators are associated with 1-year mortality in critical limb ischemia J Vasc Surg 42 2005 75 80 (Pubitemid 40966079)
12. C.D. Owens, F.J. Rybicki, N. Wake, A. Schanzer, D. Mitsouras, M.D. Gerhard-Herman Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation J Vasc Surg 47 2008 1235 1242
13. C.D. Owens, J.M. Kim, N.D. Hevelone, A. Hamdan, J.D. Raffetto, M.A. Creager Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein J Vasc Surg 51 2010 1152 1159
14. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of diet in renal disease study group Ann Intern Med 130 1999 461 470 (Pubitemid 29135798)
15. F.E. Harrell Jr, K.L. Lee, D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387 (Pubitemid 26072233)
16. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr, R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion: 207-12 (Pubitemid 351193639)
17. H.J. Moshage, H.M. Roelofs, J.F. van Pelt, B.P. Hazenberg, M.A. van Leeuwen, P.C. Limburg The effect of interleukin-1, interleukin-6 and its interrelationship on the synthesis of serum amyloid A and C-reactive protein in primary cultures of adult human hepatocytes Biochem Biophys Res Commun 155 1988 112 117
18. C.D. Owens, K.J. Ho, S. Kim, A. Schanzer, J. Lin, E. Matros Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification J Vasc Surg 45 2007 944 952 (Pubitemid 46634932)
19. D.M. Lloyd-Jones Cardiovascular risk prediction: basic concepts, current status, and future directions Circulation 121 2010 1768 1777
20. M.H. Criqui, L.A. Ho, J.O. Denenberg, P.M. Ridker, C.L. Wassel, M.M. McDermott Biomarkers in peripheral arterial disease patients and near- and longer-term mortality J Vasc Surg 52 2010 85 90
21. L. Doweik, T. Maca, M. Schillinger, A. Budinsky, S. Sabeti, E. Minar Fibrinogen predicts mortality in high risk patients with peripheral artery disease Eur J Vasc Endovasc Surg 26 2003 381 386 (Pubitemid 37266146)
22. J.E. Morley, D.R. Thomas, M.M. Wilson Cachexia: pathophysiology and clinical relevance Am J Clin Nutr 83 2006 735 743 (Pubitemid 44713134)
23. A. Saini, N. Al-Shanti, C.E. Stewart Waste management - cytokines, growth factors and cachexia Cytokine Growth Factor Rev 17 2006 475 486 (Pubitemid 44793120)
24. S.D. Anker, P.P. Ponikowski, A.L. Clark, F. Leyva, M. Rauchhaus, M. Kemp Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure Eur Heart J 20 1999 683 693 (Pubitemid 29204354)
25. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, D.L. Mann Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST) Circulation 103 2001 2055 2059 (Pubitemid 32373007)
26. J. Walsmith, L. Abad, J. Kehayias, R. Roubenoff Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis J Rheumatol 31 2004 23 29 (Pubitemid 38067517)
27. E. Myasoedova, C.S. Crowson, H.M. Kremers, V.L. Roger, P.D. Fitz-Gibbon, T.M. Therneau Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease Ann Rheum Dis 70 2011 482 487
28. P. Hu, T.E. Seeman, T.B. Harris, D.B. Reuben Does inflammation or undernutrition explain the low cholesterol-mortality association in high-functioning older persons? MacArthur studies of successful aging J Am Geriatr Soc 51 2003 80 84 (Pubitemid 36119939)
29. A. Shenkin Serum prealbumin: is it a marker of nutritional status or of risk of malnutrition? Clin Chem 52 2006 2177 2179 (Pubitemid 44924987)
30. Y. Ingenbleek, V.R. Young Significance of transthyretin in protein metabolism Clin Chem Lab Med 40 2002 1281 1291 (Pubitemid 36024669)
31. P.M. Ridker Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT) J Thromb Haemost 7 Suppl 1 2009 332 339
32. S.M. Marcora, K.R. Chester, G. Mittal, A.B. Lemmey, P.J. Maddison Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis Am J Clin Nutr 84 2006 1463 1472 (Pubitemid 44912832)
33. G. Akner, T. Cederholm Treatment of protein-energy malnutrition in chronic nonmalignant disorders Am J Clin Nutr 74 2001 6 24 (Pubitemid 32574907)
34. D.P. Kotler Cachexia Ann Intern Med 133 2000 622 634